The Tor and PKA signaling pathways independently target the Atg1/Atg13 protein kinase complex to control autophagy. Proc Natl Acad Sci USA

Department of Molecular Genetics, The Ohio State University, Columbus, OH 43210, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 10/2009; 106(40):17049-54. DOI: 10.1073/pnas.0903316106
Source: PubMed


Macroautophagy (or autophagy) is a conserved degradative pathway that has been implicated in a number of biological processes, including organismal aging, innate immunity, and the progression of human cancers. This pathway was initially identified as a cellular response to nutrient deprivation and is essential for cell survival during these periods of starvation. Autophagy is highly regulated and is under the control of a number of signaling pathways, including the Tor pathway, that coordinate cell growth with nutrient availability. These pathways appear to target a complex of proteins that contains the Atg1 protein kinase. The data here show that autophagy in Saccharomyces cerevisiae is also controlled by the cAMP-dependent protein kinase (PKA) pathway. Elevated levels of PKA activity inhibited autophagy and inactivation of the PKA pathway was sufficient to induce a robust autophagy response. We show that in addition to Atg1, PKA directly phosphorylates Atg13, a conserved regulator of Atg1 kinase activity. This phosphorylation regulates Atg13 localization to the preautophagosomal structure, the nucleation site from which autophagy pathway transport intermediates are formed. Atg13 is also phosphorylated in a Tor-dependent manner, but these modifications appear to occur at positions distinct from the PKA phosphorylation sites identified here. In all, our data indicate that the PKA and Tor pathways function independently to control autophagy in S. cerevisiae, and that the Atg1/Atg13 kinase complex is a key site of signal integration within this degradative pathway.

5 Reads
  • Source
    • "Consequently, in addition to p62 and the ubiquitination machinery, cAMP signalling could be misregulated in these cases, leading to hyperphosphorylation of p62 at Ser24, suppression of homopolymerisation and hence a reduction in autophagy . Interestingly, recent data from the yeast S. cerevisiae shows that increased cAMP/PKA activity blocks autophagy [39], and that inactivation of the cAMP pathway induces autophagy [40]. However, yeast do not express p62 or homologues thereof, and the autophagyregulating protein Atg13 was identified as the responsible PKA substrate in this case. "
    [Show abstract] [Hide abstract]
    ABSTRACT: p62, also known as SQSTM1, is a multi-domain signalling scaffold protein involved in numerous critical cellular functions such as autophagy, apoptosis and inflammation. Crucial interactions relevant to these functions are mediated by the N-terminal Phox and Bem1p (PB1) domain, which is divided into two interaction surfaces, one of predominantly acidic and one of basic character. Most known interaction partners, including atypical protein kinase C (aPKC), bind to the basic surface, and acidic-basic interactions at this interface also allow for p62 homopolymerisation. We identify here that the coupling of p62 to the cAMP signalling system is conferred by both the direct binding of cAMP degrading phosphodiesterase-4 (PDE4) to the acidic surface of the p62 PB1 domain and the phosphorylation of the basic surface of this domain by cAMP-dependent protein kinase (PKA). Such phosphorylation is a previously unknown means of regulating PB1 domain interaction partnerships by disrupting the interaction of p62 with basic surface binding partners, such as aPKCs, as well as p62 homopolymerisation. Thus, we uncover a new regulatory mechanism that connects cAMP signalling with the p62 multi-domain signalling scaffold and autophagy cargo receptor protein.
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 08/2014; 1843(11). DOI:10.1016/j.bbamcr.2014.07.021 · 5.02 Impact Factor
  • Source
    • "The inhibition of MTOR signaling by glucagon was later shown to proceed through a mechanism dependent on protein kinase A ( Kimball et al . 2004 ) , which stimulates autophagy ( Mavrakis et al . 2006 ) . It must be pointed out that , in contrast to mammalian cells , activation of protein kinase A in yeast cells inhibits autophagy ( Stephan et al . 2009 ) . In this context , it is important to stress that the function of cAMP in yeast , in contrast to that in mamma - lian cells , is to stimulate cell growth ( Thevelein and de Winde 1999 ) ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Amino acids not only participate in intermediary metabolism but also stimulate insulin-mechanistic target of rapamycin (MTOR)-mediated signal transduction which controls the major metabolic pathways. Among these is the pathway of autophagy which takes care of the degradation of long-lived proteins and of the elimination of damaged or functionally redundant organelles. Proper functioning of this process is essential for cell survival. Dysregulation of autophagy has been implicated in the etiology of several pathologies. The history of the studies on the interrelationship between amino acids, MTOR signaling and autophagy is the subject of this review. The mechanisms responsible for the stimulation of MTOR-mediated signaling, and the inhibition of autophagy, by amino acids have been studied intensively in the past but are still not completely clarified. Recent developments in this field are discussed.
    Amino Acids 06/2014; 47(10). DOI:10.1007/s00726-014-1765-4 · 3.29 Impact Factor
  • Source
    • "Target of rapamycin protein kinase complex 1 and Sch9 function in networks to regulate cellular processes, and one network link is with (PKA) which, like TORC1 and Sch9, plays roles in nutrient and stress sensing and CLS (Fig. 1A) (Soulard et al., 2010; De Virgilio, 2012; Longo et al., 2012). To determine whether the combination drug treatment lowers PKA activity, we examined Atg13 phosphorylation , as the phosphorylated form of this protein maintains autophagic flux at a low basal level in log-phase cells (Stephan et al., 2009). Combination drug treatment causes a decrease in PKA-mediated phosphorylation of Atg13 compared with single or no drug treatment (Fig. 4D, top panel). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Disease incidence rises rapidly with age and increases both human suffering and economic hardship while shortening life. Advances in understanding the signaling pathways and cellular processes that influence aging, support the possibility of reducing the incidence of age-related diseases and increasing lifespan by pharmacological intervention. Here, we demonstrate a novel pharmacological strategy that both reduces signs of aging in the budding yeast Saccharomyces cerevisiae and generates a synergistic increase in lifespan. By combining a low dose of rapamycin, to reduce activity of the target of rapamycin complex 1 (TORC1) protein kinase, and myriocin, to reduce sphingolipid synthesis, we show enhancement of autophagy, genomic stability, mitochondrial function, and AMP kinase pathway activity. These processes are controlled by evolutionarily conserved signal transduction pathways that are vital for maintaining a healthy state and promoting a long life. Thus, our data show that it ought to be possible to find pharmacological approaches to generate a synergistic reduction in the incidence of human age-related diseases to improve health quality in the elderly and enhance lifespan. This article is protected by copyright. All rights reserved.
    Aging cell 04/2013; 12(4). DOI:10.1111/acel.12090 · 6.34 Impact Factor
Show more


5 Reads
Available from